BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 32751357)

  • 1. Recent Advances on Biomarkers of Early and Late Kidney Graft Dysfunction.
    Quaglia M; Merlotti G; Guglielmetti G; Castellano G; Cantaluppi V
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of early post-operative plasma ddcfDNA levels in kidney transplantation: a single-center pilot study.
    Shen J; Zhou Y; Chen Y; Li X; Lei W; Ge J; Peng W; Wu J; Liu G; Yang G; Shi H; Chen J; Jiang T; Wang R
    Transpl Int; 2019 Feb; 32(2):184-192. PubMed ID: 30198148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation.
    Gielis EM; Ledeganck KJ; Dendooven A; Meysman P; Beirnaert C; Laukens K; De Schrijver J; Van Laecke S; Van Biesen W; Emonds MP; De Winter BY; Bosmans JL; Del Favero J; Abramowicz D
    Nephrol Dial Transplant; 2020 Apr; 35(4):714-721. PubMed ID: 31106364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes.
    Baron D; Giral M; Brouard S
    Transpl Int; 2015 Aug; 28(8):938-59. PubMed ID: 25851900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients' Survival.
    Trailin AV; Ostapenko TI; Nykonenko TN; Nesterenko SN; Nykonenko OS
    Dis Markers; 2017; 2017():9264904. PubMed ID: 28694560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of delayed graft function, acute rejection and chronic allograft dysfunction on kidney allograft telomere length in patients after transplantation: a prospective cohort study.
    Domański L; Kłoda K; Kwiatkowska E; Borowiecka E; Safranow K; Drozd A; Ciechanowicz A; Ciechanowski K
    BMC Nephrol; 2015 Feb; 16():23. PubMed ID: 25884882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
    Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
    J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid Biopsies to Monitor Solid Organ Transplant Function: A Review of New Biomarkers.
    Verhoeven JGHP; Boer K; Van Schaik RHN; Manintveld OC; Huibers MMH; Baan CC; Hesselink DA
    Ther Drug Monit; 2018 Oct; 40(5):515-525. PubMed ID: 29957668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring genetic and non-genetic risk factors for delayed graft function, acute and subclinical rejection in renal transplant recipients.
    Moes DJ; Press RR; Ackaert O; Ploeger BA; Bemelman FJ; Diack C; Wessels JA; van der Straaten T; Danhof M; Sanders JS; Homan van der Heide JJ; Guchelaar HJ; de Fijter JW
    Br J Clin Pharmacol; 2016 Jul; 82(1):227-37. PubMed ID: 27334415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The early diagnosis of acute renal graft dysfunction: a challenge we face. The role of novel biomarkers.
    Halawa A
    Ann Transplant; 2011; 16(1):90-8. PubMed ID: 21436782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early kinetics of donor-derived cell-free DNA after transplantation predicts renal graft recovery and long-term function.
    Cucchiari D; Cuadrado-Payan E; Gonzalez-Roca E; Revuelta I; Argudo M; Ramirez-Bajo MJ; Ventura-Aguiar P; Rovira J; Bañon-Maneus E; Montagud-Marrahi E; Rodriguez-Espinosa D; Cacho J; Arana C; Torregrosa V; Esforzado N; Cofàn F; Oppenheimer F; Musquera M; Peri L; Casas S; Dholakia S; Palou E; Campistol JM; Bayés B; Puig JA; Diekmann F
    Nephrol Dial Transplant; 2023 Dec; 39(1):114-121. PubMed ID: 37715343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Markers for Transplant Rejection.
    Argani H
    Exp Clin Transplant; 2020 Jan; 18(Suppl 1):1-9. PubMed ID: 32008484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients.
    Park S; Guo K; Heilman RL; Poggio ED; Taber DJ; Marsh CL; Kurian SM; Kleiboeker S; Weems J; Holman J; Zhao L; Sinha R; Brietigam S; Rebello C; Abecassis MM; Friedewald JJ
    Clin J Am Soc Nephrol; 2021 Oct; 16(10):1539-1551. PubMed ID: 34620649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction therapy by anti-thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes.
    Foster CE; Weng RR; Piper M; Laugenou K; Ichii H; Lakey J; Malinoski D
    Transplant Proc; 2012 Jan; 44(1):164-6. PubMed ID: 22310605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in Serum Amylase and Resistive Index After Kidney Transplant Are Biomarkers of Delayed Graft Function.
    Comai G; Baraldi O; Cuna V; Corradetti V; Angeletti A; Brunilda S; Capelli I; Cappuccilli M; LA Manna G
    In Vivo; 2018; 32(2):397-402. PubMed ID: 29475927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Monitoring of Donor-derived Cell-free DNA in Kidney Transplantation.
    Filippone EJ; Farber JL
    Transplantation; 2021 Mar; 105(3):509-516. PubMed ID: 32732615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validating Early Post-Transplant Outcomes Reported for Recipients of Deceased Donor Kidney Transplants.
    Potluri VS; Parikh CR; Hall IE; Ficek J; Doshi MD; Butrymowicz I; Weng FL; Schröppel B; Thiessen-Philbrook H; Reese PP
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):324-31. PubMed ID: 26668026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic renal allograft injury: early detection, accurate diagnosis and management.
    Pascual J; Pérez-Sáez MJ; Mir M; Crespo M
    Transplant Rev (Orlando); 2012 Oct; 26(4):280-90. PubMed ID: 22902496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Impact of Delayed Graft Function in Deceased Donor Renal Transplant Recipients With and Without Donor-specific HLA-antibodies.
    Haller J; Wehmeier C; Hönger G; Hirt-Minkowski P; Gürke L; Wolff T; Steiger J; Amico P; Dickenmann M; Schaub S
    Transplantation; 2019 Sep; 103(9):e273-e280. PubMed ID: 31205266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin and adiponectin during the first week after kidney transplantation: biomarkers of graft dysfunction?
    Fonseca I; Oliveira JC; Santos J; Malheiro J; Martins LS; Almeida M; Dias L; Pedroso S; Lobato L; Henriques AC; Mendonça D
    Metabolism; 2015 Feb; 64(2):202-7. PubMed ID: 25458832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.